Treatment of cutaneous lymphoid hyperplasia with thalidomide: report of two cases

J Am Acad Dermatol. 1999 Jun;40(6 Pt 1):1005-7. doi: 10.1016/s0190-9622(99)70094-0.

Abstract

Cutaneous benign lymphoid hyperplasia is a B-cell pseudolymphoma of unknown origin. The most favored sites of involvement include the face. We report two cases involving the nose that showed complete and stable regression after a 2-month treatment course with thalidomide.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Adult
  • B-Lymphocytes
  • Dermatologic Agents / therapeutic use*
  • Facial Dermatoses / drug therapy*
  • Facial Dermatoses / pathology
  • Female
  • Humans
  • Male
  • Nose
  • Pseudolymphoma / drug therapy*
  • Pseudolymphoma / pathology
  • Thalidomide / therapeutic use*

Substances

  • Dermatologic Agents
  • Thalidomide